Search

Author/Creator Ajani, J.A.

1. A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer. (February 2019)

Authors:
Bang, Y.-J.; Kang, Y.-K.; Ng, M.; Chung, H.C.; Wainberg, Z.A.; Gendreau, S.; Chan, W.Y.; Xu, N.; Maslyar, D.; Meng, R.; Chau, I.; Ajani, J.A.
Journal:
European journal of cancer
Issue:
Volume 108(2019)
Page Start:
17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ALDH‐1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Issue 1 (28th October 2013)

Authors:
Ajani, J.A.; Wang, X.; Song, S.; Suzuki, A.; Taketa, T.; Sudo, K.; Wadhwa, R.; Hofstetter, W.L.; Komaki, R.; Maru, D.M.; Lee, J.H.; Bhutani, M.S.; Weston, B.; Baladandayuthapani, V.; Yao, Y.; Honjo, S.; Scott, A.W.; Skinner, H.D.; Johnson, R.L.; Berry, D.
Journal:
Molecular oncology
Issue:
Volume 8:Issue 1(2014:Jan.)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search